Back to top

Regeneron (REGN) Price Target Cut Amid Eylea Performance Concerns

Regeneron (REGN) Price Target Cut Amid Eylea Performance Concerns

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Regeneron Pharmaceuticals, Inc. (REGN)